Sort
261,768 grants matching “gene therapy”
Molecular Therapy Core Center
$1,021,397Richard C Boucher · Univ Of North Carolina Chapel Hill · P30 · FY2012 · DK
Functionally Validated Lentiviral siRNA libraries
$1,021,240Alex Chenchik · Cellecta, Inc. · R44 · FY2011 · RR
Human Connectomes for Low Vision, Blindness, and Sight Restoration
$1,021,163Yonggang Shi · University Of Southern California · U01 · FY2017 · EY
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,021,151Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$1,021,143University Of Florida · P01 · FY2003 · DK
Conserved Element DNA Vaccine
$1,021,081Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Understanding the Role of the Host Response in HIVSIV Infection
$1,020,955Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions
$1,020,921Cherie L Stabler · University Of Florida · UH3 · FY2021 · DK
Monoclonal Antibody Therapy for West Nile Virus
$1,020,909Michael S. Diamond · Washington University · U01 · FY2007 · AI
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,835Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2018 · CA
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,020,767Thomas Meek · Texas A&M Agrilife Research · R01 · FY2020 · AI
Capacity Enhancement Core
$1,020,703Patricia Chamberlain · Oregon Social Learning Center, Inc. · P30 · FY2010 · DA
Cellular Interactions with Thrombospondin
$1,020,647David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Pathogenesis and treatment of autoinflammatory diseases i.e.NOMID,DIRA,CANDLE
$1,020,597Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation
$1,020,315Joren C Madsen · Massachusetts General Hospital · U01 · FY2019 · AI
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,143Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2017 · CA
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
$1,020,033Walter John Curran · American College Of Radiology · RC2 · FY2010 · CA
Impact of Methamphetamine Use on the HIV Nucleome in Individuals on Antiretroviral Therapy
$1,019,871James Ivan Mullins · University Of Washington · R61 · FY2019 · DA
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,019,854Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2020 · AG
Homology-directed repair: BRCA2 and RAD51 paralogs
$1,019,784Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Homology-directed repair: BRCA2 and RAD51 paralogs
$1,019,784Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
$1,019,722Lyndsey Linke · Sivec Biotechnologies, Llc · R44 · FY2021 · AI
RNAi Screening in Hematopoietic Cells
$1,019,714Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Analysis of Innate Immune Signaling Networks
$1,019,714Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Safety of Estrogen in Lupus Erythematosus
$1,019,677Hospital For Joint Diseases Ortho Inst · U01 · FY2002 · AR